Ionis Pharmaceuticals, Inc. Public Float
Ionis Pharmaceuticals, Inc. (IONS) had Public Float of $5.28 billion as of 2025-06-30, per its 10-K filed 2026-02-26.
Financial Statements › Notes › Cover Page
dei:EntityPublicFloat · last filed 2026-02-26
- 2025-06-30: Entity Public Float $5.28B.
- 2024-06-30: Entity Public Float $5.74B.
- 2023-06-30: Entity Public Float $4.24B.
- 2022-06-30: Entity Public Float $3.80B.
| Period end | Entity Public Float |
|---|---|
| 2025-06-30 | $5.28B 10-K · filed 2026-02-26 |
| 2024-06-30 | $5.74B 10-K · filed 2025-02-19 |
| 2023-06-30 | $4.24B 10-K · filed 2024-02-21 |
| 2022-06-30 | $3.80B 10-K · filed 2023-02-22 |
| 2021-06-30 | $4.68B 10-K · filed 2022-02-25 |
| 2020-06-30 | $6.75B 10-K · filed 2021-02-24 |
| 2019-06-30 | $7.48B 10-K · filed 2020-03-02 |
| 2018-06-30 | $4.81B 10-K · filed 2019-03-01 |
| 2017-06-30 | $5.16B 10-K · filed 2018-02-28 |
| 2016-06-30 | $2.34B 10-K · filed 2017-03-01 |
| 2015-06-30 | $5.76B 10-K · filed 2016-02-26 |
| 2014-06-30 | $3.38B 10-K · filed 2015-03-02 |
| 2013-06-30 | $2.57B 10-K · filed 2014-03-03 |
| 2012-06-30 | $1.01B 10-K · filed 2013-02-28 |
| 2011-06-30 | $761.30M 10-K · filed 2012-02-29 |
| 2010-06-30 | $779.46M 10-K · filed 2011-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Spyre Therapeutics, Inc. (SYRE) | United States | $7.685B | -43.69 |
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |
| Alkermes plc. (ALKS) | $6.844B | 132.74 | |
| RHYTHM PHARMACEUTICALS, INC. (RYTM) | United States | $6.771B | -37.20 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |
| Liquidia Corp (LQDA) | United States | $6.347B | 51.23 |
| Amneal Pharmaceuticals, Inc. (AMRX) | $6.326B | 25.62 | |
| Mirum Pharmaceuticals, Inc. (MIRM) | United States | $5.798B | -8.81 |
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |
| Travere Therapeutics, Inc. (TVTX) | United States | $5.712B | -123.10 |